Inventor

CERAMI ANTHONY

US172 patents

⚠️ This page may combine multiple inventors who share the name “CERAMI ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CERAMI ANTHONY

PICOWER INST MED RES

Guanylhydrazones and their use to treat inflammatory conditions

Blood-borne mesenchymal cells

Combination method for treating diseases caused by cytokine-mediated toxicity

Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts

Preventing and reversing the formation of advanced glycosylation endproducts

Guanylhydrazones and their use to treat inflammatory conditions

Guanylhydrazones and their use to treat inflammatory conditions

Guanylhydrazones and their use to treat inflammatory conditions

Guanylhydrazones and their use to treat inflammatory conditions

Blood-borne mesenchymal cells

Modulation of immune responses in blood-borne mesenchymal cells

Guanylhydrazones and their use to treat inflammatory conditions

Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom

Guanylhydrazones and their use to treat inflammatory conditions

Guanylhydrazones and their use to treat inflammatory conditions

Blood-borne mesenchymal cells

Blood-borne mesenchymal cells

Methods and materials for the diagnosis and treatment of conditions such as stroke

Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom

Guanylhydrazones and their use to treat inflammatory conditions

Methods and materials for the diagnosis and treatment of conditions such as stroke

Methods and materials for the diagnosis and treatment of conditions such as stroke

Methods and materials for the diagnosis and treatment of conditions such as stroke

Preventing and reversing advanced glycosylation endproducts

Composition containing anti-MIF antibody

UNIV ROCKEFELLER

Method and agents for inhibiting protein aging

Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)

Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)

Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)

Monoclonal antibodies to cachectin/tumor necrosis factor and methods for preparing same

Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)

Liver-derived receptors for advanced glycosylation endproducts and uses thereof

Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles

Amino acids useful as inhibitors of the advanced glycosylation of proteins

2-alkylidene-aminoguanidines and methods of use therefor

Mesangial cell-derived receptors for advanced glycosylation endproducts and uses thereof

2-alkylidene-aminoguanidines and methods of use therefor

Method and agents for inhibiting protein aging

Method and agents for removing advanced glycosylation endproducts

2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole

Method and system for the controlled release of biologically active substances to a body fluid

Monitoring metabolic control in diabetic patients by measuring glycosylated amino acids and peptides in urine

Method and system for the controlled release of biologically active substances to a body fluid

EVREKA INC

Monitor for continuous in vivo measurement of glucose concentration

Article and method for measuring glucose level in body fluids

KENNETH S WARREN INST INC

Protection and enhancement of erythropoietin-responsive cells, tissues and organs

Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin

ALTEON INC

Method of treating certain indications associated with hyperglycemia

Reversing the formation of advanced glycosylation endproducts

(unassigned)

Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages